hcp.striverdi.com
Downloadable documents regarding STRIVERDI® RESPIMAT® (olodaterol) Inhalation Spray
https://hcp.striverdi.com/resources/documents.html
View STRIVERDI Patient Site. Information About STRIVERDI RESPIMAT at Your Fingertips. To help your patients better understand the benefits of STRIVERDI RESPIMAT and what they can expect from treatment, follow the link to download this Patient Brochure. Helpful video to help you. And your patients learn about STRIVERDI RESPIMAT. Olodaterol) Inhalation Spray is a long-acting beta. Adrenergic agonist (salmeterol) or placebo added to usual asthma therapy showed an increase in asthma-related deaths in patient...
hcp.striverdi.com
Pivotal Trials for STRIVERDI® RESPIMAT® (olodaterol) Inhalation Spray
https://hcp.striverdi.com/pivotal-trials
View STRIVERDI Patient Site. 24-Hour Bronchodilation With Effect Seen Within. 5 Minutes of the First Dose. In a 48-week study, STRIVERDI RESPIMAT demonstrated sustained improvements in. Lung function at 24 weeks. With the exception of other LABAs, all pulmonary medications were allowed as concomitant therapy (tiotropium, ipratropium, inhaled corticosteroids, and xanthines). Mean increase in FEV. Of 110 mL at 5 minutes after the first dose compared to placebo (range: 100 to 120 mL). Agonist indicated for ...
hcp.striverdi.com
STRIVERDI® RESPIMAT® (olodaterol) Inhalation Spray – safety profile
https://hcp.striverdi.com/safety
View STRIVERDI Patient Site. STRIVERDI RESPIMAT: Safety Profile. Review the safety and tolerability outcomes of STRIVERDI RESPIMAT in the link below. Examine safety results from the key STRIVERDI RESPIMAT trials. Read about the benefits of treating COPD patients with STRIVERDI RESPIMAT. Read about recommended dosing for. Olodaterol) Inhalation Spray is a long-acting beta. Important Limitations: STRIVERDI RESPIMAT is not indicated to treat acute deteriorations of COPD and is not indicated to treat asthma.
hcp.striverdi.com
STRIVERDI® RESPIMAT® (olodaterol) Inhalation Spray - How to use the Respimat
https://hcp.striverdi.com/dosing/how-to-use.html
View STRIVERDI Patient Site. Using the STRIVERDI RESPIMAT Inhaler for Daily Dosing. A helpful way to remember the 3 steps for daily dosing is to remember TOP:. Urn the clear base. Pen the cap and close your lips around the mouthpiece. Ress the dose-release button and inhale. These steps should be performed 2 times. To receive the proper dose of medication. STRIVERDI RESPIMAT must be prepared and primed before first use. View this short interactive demonstration. Read about recommended dosing for. Adrener...
hcp.striverdi.com
STRIVERDI® RESPIMAT® (olodaterol) Inhalation Spray - Rescue medication results
https://hcp.striverdi.com/pivotal-trials/rescue-medication.html
View STRIVERDI Patient Site. A Reduced Need for Rescue Medication. STRIVERDI RESPIMAT Demonstrated a 34% Reduction (1.2 Puffs/Day) in the Use of Rescue Albuterol. 34% Reduction (1.2 Puffs/Day) in Use of Rescue Albuterol. 80% of patients were taking pulmonary medications at baseline and all pulmonary medications, except LABAs, were allowed as concomitant therapy. This is a representative trial. Comparable results were achieved in 2 similarly designed trials. Phase 3 Clinical Trial Program. Trials 1 and 2.
hcp.striverdi.com
STRIVERDI® RESPIMAT® (olodaterol) Inhalation Spray - resources
https://hcp.striverdi.com/resources
View STRIVERDI Patient Site. Educational Resources for You and Your Patients. STRIVERDI RESPIMAT offers support for you and your patients in the way of educational materials and a video. Click on the links on this page to access the information you need. Helpful video to help you and your patients learn about. Olodaterol) Inhalation Spray is a long-acting beta. Important Limitations: STRIVERDI RESPIMAT is not indicated to treat acute deteriorations of COPD and is not indicated to treat asthma. STRIVERDI ...
hcp.striverdi.com
Striverdi® Respimat® (olodaterol) Inhalation Spray - Educational videos
https://hcp.striverdi.com/resources/videos.html
View STRIVERDI Patient Site. Watch and Learn About STRIVERDI RESPIMAT. Below you'll find a video you can explore to learn more about how STRIVERDI RESPIMAT is used. Explore how STRIVERDI RESPIMAT is used. Olodaterol) Inhalation Spray is a long-acting beta. Agonist indicated for long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. STRIVERDI RESPIMAT should not be initi...
hcp.striverdi.com
STRIVERDI® RESPIMAT® (olodaterol) Inhalation Spray - Dosing
https://hcp.striverdi.com/dosing
View STRIVERDI Patient Site. STRIVERDI RESPIMAT Dispenses Medication as a Slow-Moving Mist. The mist of STRIVERDI RESPIMAT is delivered by a mechanical system that nebulizes the medication as it is released. Does not use CFCs or other propellants. The duration of spray for STRIVERDI RESPIMAT is 1.5 seconds. Each prefilled cartridge contains 60 puffs (30 doses) or, in the institutional pack, 28 puffs (14 doses). Inhaler is designed with a dose indicator for patient convenience. How to Use Video. Agonist i...
hcp.striverdi.com
Safety profile from the STRIVERDI® RESPIMAT® (olodaterol) Inhalation Spray pivotal trials
https://hcp.striverdi.com/safety/pivotal-trials.html
View STRIVERDI Patient Site. Safety and Tolerability Established in 876 Patients Treated for 48 Weeks. Overall incidence of adverse. Reactions and discontinuation was similar for STRIVERDI. 72% adverse reactions; 7.2% discontinuation) and placebo (71% adverse reactions; 8.8% discontinuation). All Adverse Drug Reactions Reported by 2% of Patients. And Higher Than Placebo) Who Received STRIVERDI RESPIMAT. Read about the benefits of treating COPD patients with STRIVERDI RESPIMAT. Adrenergic agonist (salmete...